---
id: tularemia_064
category: organisms
tags: [tularemia, francisella-tularensis, rabbit-fever, bioterrorism, ulceroglandular, pneumonic, gentamicin]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Tularemia (Francisella tularensis) - "Rabbit Fever"

**Q:** What are the clinical forms of tularemia, their presentations, and treatment including bioterrorism scenarios?

**A:**

**Microbiology:**
- **Gram-negative coccobacillus** (tiny, pleomorphic)
- **Francisella tularensis**
- Facultative intracellular pathogen
- **Highly infectious:** 10-50 organisms can cause disease
- Requires cysteine-enriched media (chocolate agar, buffered charcoal yeast extract)

**Epidemiology:**
- **Zoonotic:** Rabbits (cottontail), rodents, ticks (Dermacentor, Amblyomma)
- **US:** ~200 cases/year (endemic: Arkansas, Missouri, Oklahoma, South Dakota)
- **CDC Category A bioterrorism agent** (aerosolized potential)

---

**Clinical Forms (6 Types):**

**1. Ulceroglandular Tularemia (45-85% of cases):**

**Transmission:** Tick bite, animal handling (rabbit skinning), animal bite

**Clinical Presentation:**
- **Painful papule** at inoculation site → vesicle → **ulcer with raised border**
- **Painful regional lymphadenopathy** (tender, enlarged)
  - Inguinal (tick bite on leg)
  - Axillary (handling infected animal)
- **Fever, chills, headache**
- Ulcer: Well-circumscribed, punched-out, black base

**Key Feature:** **Skin ulcer + regional painful lymphadenopathy**

**2. Glandular Tularemia (10-25%):**
- **Lymphadenopathy WITHOUT ulcer**
- Same as ulceroglandular but no visible skin lesion (inoculation site not apparent)

**3. Oculoglandular Tularemia (1-3%):**

**Transmission:** Contamination of conjunctiva (touching eyes after handling infected animal)

**Clinical Presentation:**
- **Painful conjunctivitis** (unilateral)
- **Chemosis, purulent discharge**
- **Preauricular, submandibular, or cervical lymphadenopathy**
- **Corneal ulceration** (if severe)

**4. Oropharyngeal Tularemia (1-4%):**

**Transmission:** Ingestion of contaminated water or undercooked meat

**Clinical Presentation:**
- **Severe pharyngitis**
- **Tonsillar ulcers, exudative pharyngitis**
- **Cervical lymphadenopathy**
- **Odynophagia, dysphagia**
- Can mimic strep throat or diphtheria

**5. Pneumonic Tularemia (10-15%, higher if bioterrorism):**

**Transmission:**
- **Primary:** Inhalation of aerosolized bacteria (bioterrorism, laboratory exposure, lawn mowing over infected carcass)
- **Secondary:** Hematogenous spread from other forms (bacteremia)

**Clinical Presentation:**
- **Fever, chills, headache**
- **Dry cough** (non-productive initially)
- **Chest pain, dyspnea**
- **Pleuritic chest pain**

**Imaging:**
- **Infiltrates** (patchy, lobar, or diffuse)
- **Hilar adenopathy** (prominent)
- **Pleural effusions**

**Key Feature:** **Pneumonia + hilar adenopathy**

**Prognosis:**
- **Mortality 30-60% if untreated**, <5% with treatment

**6. Typhoidal Tularemia (10-15%):**

**Presentation:**
- **Fever, chills, myalgias** WITHOUT localizing signs
- **Systemic febrile illness**
- Hepatosplenomegaly
- No skin ulcer, no lymphadenopathy
- Diagnosis of exclusion (no clear portal of entry)

---

**Diagnosis:**

**Culture:**
- **Dangerous:** F. tularensis is highly infectious (biosafety level 3)
- Alert laboratory if tularemia suspected
- Requires cysteine-enriched media (chocolate agar, BCYE)

**Serology (Most Common):**
- **Tube agglutination test** or ELISA
- Single titer ≥1:160 or 4-fold rise
- IgM/IgG
- Seroconversion takes 2-3 weeks (late diagnosis)

**PCR:**
- Available in reference labs
- Rapid

**Key Lab Findings:**
- Leukocytosis or leukopenia
- Elevated transaminases (typhoidal form)

---

**Treatment:**

**Key Principle:** Treat empirically if suspected (serology delayed 2-3 weeks)

**1. First-Line Treatment (CDC 2025 Guidelines):**

**Preferred Aminoglycosides:**

| **Antibiotic** | **Dosing** | **Duration** |
|----------------|------------|--------------|
| **Gentamicin** (preferred) | 5 mg/kg IV/IM q24h (extended-interval) | 10 days (7-10 days) |
| **Streptomycin** | 1g IM BID (or 15 mg/kg BID) | 10 days |

**Notes:**
- **Aminoglycosides most effective** (streptomycin or gentamicin)
- Gentamicin preferred (more available than streptomycin)

**Alternative First-Line:**

| **Antibiotic** | **Dosing** | **Duration** |
|----------------|------------|--------------|
| **Doxycycline** | 100 mg IV/PO q12h | 14-21 days |
| **Ciprofloxacin** | 400 mg IV q12h or 500 mg PO BID | 10-14 days |
| **Levofloxacin** | 750 mg IV/PO q24h | 10-14 days |

**Notes:**
- **Doxycycline first-line for glandular/ulceroglandular** (randomized trial showed efficacy)
- **Fluoroquinolones effective** (ciprofloxacin, levofloxacin)
- **Higher relapse rate** with tetracyclines/fluoroquinolones (10-20%) vs aminoglycosides (<5%)

**2. Treatment by Form:**

**Ulceroglandular/Glandular/Oculoglandular/Oropharyngeal:**
- **Doxycycline** 100 mg PO BID x 14-21 days (preferred for mild-moderate)
- **Gentamicin** (if severe)
- **Ciprofloxacin** (alternative)

**Pneumonic/Typhoidal (Severe):**
- **Gentamicin** 5 mg/kg IV q24h x 10 days (preferred)
- **Streptomycin** (if available)
- Alternative: Ciprofloxacin or levofloxacin

**Meningitis (Rare):**
- Gentamicin or streptomycin
- Consider adding rifampin or chloramphenicol (better CSF penetration)

**Pediatric:**
- Gentamicin: 2.5 mg/kg IV/IM q8h or 5-7.5 mg/kg q24h
- Doxycycline: Use despite age (serious infection)

**3. Treatment Failure Concerns:**
- **Oropharyngeal tularemia:** Gentamicin treatment failure reported in children
- May require prolonged therapy or switch to fluoroquinolone

---

**Post-Exposure Prophylaxis (PEP) - Bioterrorism:**

**Indications:**
- Laboratory exposure to aerosolized F. tularensis
- Bioterrorism event (mass aerosolized exposure)

**Regimen (14 days):**

| **Antibiotic** | **Dosing** |
|----------------|------------|
| **Doxycycline** (preferred) | 100 mg PO BID x 14 days |
| **Ciprofloxacin** | 500 mg PO BID x 14 days |

---

**Bioterrorism Scenario:**

**Aerosolized F. tularensis:**
- **Pneumonic tularemia** (primary)
- Incubation 3-5 days
- Sudden surge of **pneumonia cases with hilar adenopathy**
- **High morbidity** (30-60% mortality untreated)
- NOT person-to-person (unlike pneumonic plague)

**Response:**
- Mass PEP (doxycycline or ciprofloxacin x 14 days)
- Early treatment with gentamicin or fluoroquinolone

---

**Comparison: Tularemia vs Plague vs Anthrax (Bioterrorism)**

| **Feature** | **Tularemia** | **Plague** | **Anthrax** |
|-------------|---------------|------------|-------------|
| **Organism** | F. tularensis | Y. pestis | B. anthracis |
| **Inoculum** | 10-50 (very low) | Low | 8,000-50,000 |
| **Pneumonic mortality** | 30-60% (untreated) | Nearly 100% | 45-90% |
| **Person-to-person** | ❌ No | ✅ Yes (droplet) | ❌ No |
| **Key imaging** | **Hilar adenopathy** | Bilateral infiltrates | **Widened mediastinum** |
| **First-line Rx** | **Gentamicin** | Gentamicin/doxycycline | Ciprofloxacin + linezolid |
| **PEP duration** | 14 days | 7 days | 60 days |

---

**Mnemonic: "TULAREMIA = Tick/rabbit Ulcer, Lymph Adenopathy, Requires Empiric Aminoglycosides"**
- **T**ick bite or rabbit exposure
- **U**lcer (punched-out with raised border)
- **L**ymph adenopathy (painful, regional)
- **A**minosglycosides (gentamicin first-line)
- **R**abbit fever
- **E**mpire treatment (don't wait for serology)
- **M**ultiple forms (6 types)
- **I**nhalation → pneumonic (bioterrorism)
- **A**lert lab (biosafety level 3)

**Mnemonic: "Pneumonic Tularemia = Hilar adenopathy"**
- **Hilar adenopathy** = key imaging finding
- Distinguishes from pneumonic plague or anthrax

**Clinical Pearls:**
- **Ulceroglandular tularemia: Skin ulcer + painful regional lymphadenopathy** after rabbit/tick exposure
- **Rabbit fever** (classic nickname)
- **Alert microbiology lab** if tularemia suspected (highly infectious, BSL-3)
- **Gentamicin first-line** for severe/pneumonic (streptomycin if available)
- **Doxycycline first-line** for ulceroglandular/glandular (milder forms)
- **Fluoroquinolones effective** but higher relapse rate (10-20%)
- **Pneumonic tularemia: Pneumonia + hilar adenopathy** (bioterrorism concern)
- **Not person-to-person** (unlike pneumonic plague)
- **PEP: 14 days** (doxycycline or ciprofloxacin)
- **Serology delayed** (2-3 weeks) → treat empirically
- Oropharyngeal form can mimic strep throat or diphtheria
- **6 clinical forms** based on route of exposure

**Media:** None

**Sources:** [CDC MMWR 2025 - Tularemia antimicrobial treatment], [CDC 2024 - Tularemia clinical care], [Frontiers 2023 - Tularemia treatment review], [CID 2024 - Systematic review 1993-2023], [CID 2024 - US surveillance 2006-2021], [Medscape 2024 - Tularemia medication], [PMC 2018 - Tetracyclines for tularemia], [MSD Manual 2024 - Tularemia]
